However, HER2 testing in gastric cancer differs from that in breast cancer due to inherent differences in the tumor biology, an intratumoral heterogeneity of HER2 expression, as well as an incomplete staining on the membranes that is frequently detected in gastric tumors [21]. This evidence concerns the gene ERBB2 and breast carcinoma.